Abstract
Obesity has become a worldwide epidemic and impacts cardiovascular health. It is closely associated with hypertension, diabetes and dyslipidemia which are known precursors of cardiovascular disease and have a significant impact on overall morbidity and mortality. Obesity has been identified as an independent risk factor in the development of dilated cardiomyopathy. This article will review the cardiovascular consequences of obesity and highlight some of the pathophysiologic derangements that have been identified to be associated with obesity.
Keywords: Obesity, diabetes, hypertension, dyslipidemia, cardiomyopathy, coronary artery disease
Current Respiratory Medicine Reviews
Title: Cardiovascular Complications of Obesity
Volume: 4 Issue: 2
Author(s): Gerard Oghlakian and Marc Klapholz
Affiliation:
Keywords: Obesity, diabetes, hypertension, dyslipidemia, cardiomyopathy, coronary artery disease
Abstract: Obesity has become a worldwide epidemic and impacts cardiovascular health. It is closely associated with hypertension, diabetes and dyslipidemia which are known precursors of cardiovascular disease and have a significant impact on overall morbidity and mortality. Obesity has been identified as an independent risk factor in the development of dilated cardiomyopathy. This article will review the cardiovascular consequences of obesity and highlight some of the pathophysiologic derangements that have been identified to be associated with obesity.
Export Options
About this article
Cite this article as:
Oghlakian Gerard and Klapholz Marc, Cardiovascular Complications of Obesity, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222632
DOI https://dx.doi.org/10.2174/157339808784222632 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treating Heart Failure with Preserved Ejection Fraction Related to Arterial Stiffness. Can we Kill Two Birds With One Stone?
Current Vascular Pharmacology microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound Phenomenon
Current Vascular Pharmacology Role of Chymase in Preeclampsia
Current Vascular Pharmacology Anticancer Drug Combinations, How Far We can Go Through?
Anti-Cancer Agents in Medicinal Chemistry COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19
Current Medicinal Chemistry FKBP Ligands as Novel Therapeutics for Neurological Disorders
Mini-Reviews in Medicinal Chemistry Hemodynamic Assessment and In vivo Catabolism of Adenosine 5’-triphosphate in Doxorubicin or Isoproterenol-induced Cardiovascular Toxicity
Drug Metabolism Letters MicroRNA Therapeutics for Cardiac Regeneration
Mini-Reviews in Medicinal Chemistry An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
Mini-Reviews in Medicinal Chemistry New Developments in Anthracycline-Induced Cardiotoxicity
Current Medicinal Chemistry Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Treating Nonthyroidal Illness Syndrome in the Critically Ill Patient: Still a Matter of Controversy
Current Drug Targets Potential of Resveratrol in Preventing the Development of Heart Failure
Current Chemical Biology Models and Methods in Cardiac Imaging for Metabolism Studies
Current Pharmaceutical Design Getting to the Heart of the Matter: Exploring Opportunities for Gene Therapy Treatment of Dystrophic Cardiomyopathy
Current Gene Therapy High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Challenges in Chagas Disease Drug Discovery: A Review
Current Medicinal Chemistry The Role of Toll-Like Receptor Pathways in the Mechanism of Type 1 Diabetes
Current Molecular Medicine